AMH and Hodgkins lymphoma: BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisolone) resulted in the most substantial decline (28), whereas ABV-treated Hodgkins’ lymphoma patients exhibited partial AMH recovery (23, 28).